#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2382	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2469	233.2	0	.	n	.	0	C451T	SNP	451	451	C	928	928	T	314	T,C,G,A	162,112,6,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2382	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2469	233.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1661	1661	C	272	C,A,T	254,3,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2382	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2469	233.2	0	HET	.	.	.	C207T,A	.	207	207	C	684	684	C	226	C,T,A	156,38,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4010	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4288	231.6	0	.	n	.	0	T695C	SNP	695	695	T	1394	1394	C	212	C,A,T,G	197,3,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4010	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4288	231.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2670	2670	C	302	C,A	285,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4010	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4288	231.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2744	2744	A	303	A,T	287,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4010	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4288	231.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	3296	3296	C	325	C,G,A	311,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	580	folP	855	855	100.0	folP.l6.c4.ctg.1	2030	70.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1297	1299	AGC	85;84;84	A,C;G;C	79,2;81;80	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	958	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3927	60.0	1	SNP	p	S91F	1	.	.	271	273	TTC	877	879	TTC	66;66;67	T,A,G;T;C	51,1,1;57;61	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	958	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3927	60.0	1	SNP	p	D95G	1	.	.	283	285	GGC	889	891	GGC	68;68;68	G;G;C	62;62;62	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	958	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3927	60.0	1	SNP	p	G95N	0	.	.	283	285	GGC	889	891	GGC	68;68;68	G;G;C	62;62;62	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	396	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1776	55.4	1	SNP	p	G45D	0	.	.	133	135	GGC	696	698	GGC	97;97;99	G;G;C	87;83;90	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	244	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1572	38.2	0	.	n	.	0	A197.	DEL	197	197	A	871	871	A	83	A	75	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1116	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3469	79.5	1	SNP	p	D86N	0	.	.	256	258	GAC	835	837	GAC	75;74;75	G,T;A,T;C	55,1;50,2;62	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1116	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3469	79.5	1	SNP	p	R87W	0	.	.	259	261	CGT	838	840	CGT	75;75;73	C;G,A;T	65;55,1;57	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1116	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3469	79.5	1	SNP	p	R87I	0	.	.	259	261	CGT	838	840	CGT	75;75;73	C;G,A;T	65;55,1;57	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1116	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3469	79.5	1	SNP	p	S87R	1	.	.	259	261	CGT	838	840	CGT	75;75;73	C;G,A;T	65;55,1;57	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1116	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3469	79.5	1	SNP	p	S88P	0	.	.	262	264	TCC	841	843	TCC	73;73;73	T;C;C,G	59;61;63,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	900	parE	1986	1986	100.0	parE.l6.c4.ctg.1	3180	69.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1829	1831	GGC	87;88;88	G,C;G,C;C,G,A	71,1;71,1;70,1,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	684	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2594	63.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1540	1542	GCC	80;80;79	G,C;C,A;C	75,1;72,4;76	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	684	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2594	63.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1543	1545	ATG	79;79;79	A,G;T,G;G,A	75,2;74,3;77,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	684	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2594	63.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1555	1557	ACC	81;81;81	A,G;C;C,T	71,3;79;78,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	684	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2594	63.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1555	1557	ACC	81;81;81	A,G;C;C,T	71,3;79;78,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	684	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2594	63.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2056	2058	ACC	75;75;74	A,C;C,A,G;C,A	65,1;54,3,1;64,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	684	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2594	63.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2110	2112	GCG	69;69;69	G;C;G,T	59;51;58,4	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	684	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2594	63.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2110	2112	GCG	69;69;69	G;C;G,T	59;51;58,4	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	684	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2594	63.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2233	2235	GGT	52;52;53	G;G,T;T	49;44,3;49	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	684	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2594	63.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2242	2244	AGC	51;51;50	A;G,C;C	42;42,1;42	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	684	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2594	63.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2260	2262	CCG	39;36;36	C,G;C;G,C	29,1;26;25,3	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	916	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3393	66.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1745	1747	CCG	80;81;81	C;C;G,A,C	53;68;57,2,2	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	454	porA	1146	1146	99.91	porA.l15.c17.ctg.1	2111	53.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	596	596	C	55	C,G	48,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	396	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	2195	44.8	1	SNP	p	G120K	1	.	.	358	360	AAG	925	927	AAG	59;60;62	A;A,T,C;G,T,C,A	53;53,1,1;57,1,1,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	396	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	2195	44.8	1	SNP	p	N121D	0	.	.	361	363	AAC	928	930	AAC	62;62;62	A;A;C	57;57;59	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	396	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	2195	44.8	1	SNP	p	A121N	1	.	.	361	363	AAC	928	930	AAC	62;62;62	A;A;C	57;57;59	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1110	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	5388	51.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	134	rpsJ	312	312	100.0	rpsJ.l6.c17.ctg.1	1450	22.9	1	SNP	p	V57M	1	.	.	169	171	ATG	746	748	ATG	38;38;38	A;T;G,T	35;38;37,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
